Table 1 Clinical Input Data for Payer Model
Variables | Base-case | Article References |
|---|---|---|
Average age of cohort | 64 | [25] |
Prevalence of HF stage B+ after Charlson screening | 0.2 | Pretest assumption |
Outcomes discount rate | 3% | [40] |
SENC Rest Diagnostic Accuracy | 1 | [18] |
4-year progression in prevalence of stage B | 0.154 | [41] |
ECHO at rest | ||
 Stage C | 4.27% | [42] |
 Stage C+ | 4.55% | [42] |
 Stage D | 4.50% | [26] |
 Mortality | 6.94% | [42] |
Fast-SENC | ||
 Stage C | 3.11% | [42] |
 Stage C+ | 3.32% | [42] |
 Stage D | 3.28% | Assumption |
 Mortality | 5.43% | [42] |
Percent of Heart Failure Hospitalizations that are Preventable | 54.20% | [16] |
50% reduction in preventable hospitalization for SENC | 27.10% | Assumption |
HF hospitalization (annualized rate) | 32.02% | [17] |
30-day HF rehospitalization | 26.90% | [43] |